Outset Medical, Inc. (OM)
NASDAQ: OM · IEX Real-Time Price · USD
2.400
+0.020 (0.84%)
Apr 26, 2024, 4:00 PM EDT - Market closed
Outset Medical Market Cap
Outset Medical has a market cap or net worth of $121.21 million as of April 26, 2024. Its market cap has decreased by -86.03% in one year.
Market Cap
121.21M
Enterprise Value
50.75M
1-Year Change
-86.03%
Ranking
Category
Stock Price
$2.40
Market Cap Chart
Since the IPO on September 15, 2020, Outset Medical's market cap has decreased from $1.07B to $121.21M, a decrease of -88.66%. That is a compound annual growth rate of -45.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 26, 2024 | 121.20M | 0.83% |
Apr 25, 2024 | 120.20M | -6.68% |
Apr 24, 2024 | 128.80M | 3.70% |
Apr 23, 2024 | 124.20M | 5.08% |
Apr 22, 2024 | 118.20M | 0.85% |
Apr 19, 2024 | 117.20M | 3.17% |
Apr 18, 2024 | 113.60M | 4.12% |
Apr 17, 2024 | 109.10M | 3.81% |
Apr 16, 2024 | 105.10M | 2.04% |
Apr 15, 2024 | 103.00M | -0.48% |
Apr 12, 2024 | 103.50M | -9.92% |
Apr 11, 2024 | 114.90M | -1.71% |
Apr 10, 2024 | 116.90M | -7.81% |
Apr 9, 2024 | 126.80M | -0.78% |
Apr 8, 2024 | 127.80M | 23.48% |
Apr 5, 2024 | 103.50M | 5.61% |
Apr 4, 2024 | 98.00M | -4.39% |
Apr 3, 2024 | 102.50M | 0.99% |
Apr 2, 2024 | 101.50M | -3.43% |
Apr 1, 2024 | 105.10M | -6.24% |
Mar 28, 2024 | 112.10M | 0.90% |
Mar 27, 2024 | 111.10M | - |
Mar 26, 2024 | 111.10M | 7.03% |
Mar 25, 2024 | 103.80M | 3.28% |
Mar 22, 2024 | 100.50M | -4.83% |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Sagimet Biosciences | 125.10M |
Karyopharm Therapeutics | 123.45M |
Coya Therapeutics | 122.59M |
Amylyx Pharmaceuticals | 120.65M |
InterCure | 120.31M |
Cardiol Therapeutics | 119.81M |
PDS Biotechnology | 119.57M |
Xtant Medical Holdings | 117.39M |